Ledger.Open graph →
SEC Form D · filed April 21, 2022

Aurion Biotech, Inc

Offering
$120.3M
Sold
$55.3M
Exemption
Rule 506(c)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (27)

Andrew Elbardissi · SEATTLE, WADirectorGreg Kunst · SEATTLE, WAExec · DirectorDavid Rostov · SEATTLE, WAExecLink William · SEATTLE, WADirectorArnaud Lacoste · SEATTLE, WAExecTom Frinzi · SEATTLE, WADirectorChristine Mccauley · SEATTLE, WADirectorJeannette Bankes · SEATTLE, WADirectorPatrick Lally · SEATTLE, WADirectorJennifer Stapp · Long Beach, CAExecAri Herman · New York, NYDirectorRich Johnson · Long Beach, CAExecWhite Robert · Long Beach, CADirectorJustin Ryvicker · Whippany, NJExec · DirectorJonathan Bain · Grand Cayman, Cayman IslandsDirectorSwitzer Robert · Long Beach, CADirectorElvin Lopez · Whippany, NJDirectorJennifer Frist · NASHVILLE, TNDirectorNatan Linder · Boston, MADirectorUdayan Umapathi · Boston, MADirectorConnie Wang · Austin, TXExec · DirectorRob Carlson · Frederick, MDDirectorDaniella Kranjac · Frederick, MDDirectorJon Rowley · Frederick, MDExecTimothy Kelly · Frederick, MDDirectorRobert Preti · Frederick, MDExecEric Patterson · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗